OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Copper homeostasis and cuproptosis in cardiovascular disease therapeutics
Lifang Yang, Pingping Yang, Gregory Y.H. Lip, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 9, pp. 573-585
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Yumin Wang, Yongming Chen, Junjing Zhang, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101018-101018
Open Access | Times Cited: 89

Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies
Shengjie Yang, Yujuan Li, Zhou Li-jun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 26

Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review
Sara Abdolmaleki, Alireza Aliabadi, Samad Khaksar
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 23

Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 20

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18

Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
Xiangdong Liu, Bo Luo, Xinhong Wu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189013-189013
Closed Access | Times Cited: 27

Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases
Zhibo Yang, Ridong Feng, Zhao Hai
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1330-1360
Closed Access | Times Cited: 12

Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases
Juanjuan Han, Jiayi Luo, C Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116570-116570
Open Access | Times Cited: 11

Programmed Lung Metastasis Immunotherapy via Cascade‐Responsive Cell Membrane‐Mimetic Copolymer‐Wrapped Nanoraspberry‐Mediated Elesclomol‐Copper Delivery
Thi My Hue Huynh, Van‐Sieu Luc, Min‐Ren Chiang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 34
Closed Access | Times Cited: 11

Copper’s dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases
Rajesh Parsanathan
Hypertension Research (2024) Vol. 47, Iss. 5, pp. 1440-1442
Closed Access | Times Cited: 8

Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases
Yurong Zou, Shukun Wu, Xingli Xu, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112075-112075
Closed Access | Times Cited: 8

Copper metabolism and its role in diabetic complications: A review
Dongkai Jia, Lulu Liu, Wei Liu, et al.
Pharmacological Research (2024) Vol. 206, pp. 107264-107264
Open Access | Times Cited: 8

Phenanthroline and Schiff Base associated Cu(II)-coordinated compounds containing N, O as donor atoms for potent anticancer activity
Richa Richa, Vinod Kumar, Ramesh Kataria
Journal of Inorganic Biochemistry (2023) Vol. 251, pp. 112440-112440
Closed Access | Times Cited: 17

The roles of essential trace elements in T cell biology
Linbo Lan, Feng Zhao, Xiaobin Liu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 6

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment
Dahye Noh, Hokyung Lee, Sangmin Lee, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 5

Metallothionein rescues doxorubicin cardiomyopathy via mitigation of cuproptosis
Yan Liu, Mingzhi Shen, Shuyi Zhu, et al.
Life Sciences (2025) Vol. 363, pp. 123379-123379
Closed Access

The molecular mechanisms of cuproptosis and its relevance to atherosclerosis
Jiankang Wang, Zhian Chen, Hang Shang, et al.
Biomolecules and Biomedicine (2025)
Open Access

Programmed cardiomyocyte death in myocardial infarction
Hao Wu, Qi Lan, Yi-Xiang He, et al.
APOPTOSIS (2025)
Closed Access

Aprocitentan mitigates doxorubicin-induced cardiotoxicity by inhibiting cuproptosis, oxidative stress, and mitochondrial impairments via the activation of sirtuin 7
Yufei Chen, Rui-Qiang Qi, Zhao Lin, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114141-114141
Closed Access

Recent advancements in the application of multi-elemental profiling and ionomics in cardiovascular diseases
Yan Zhang, Zaicheng Zhang, Hanyang Li, et al.
Journal of Trace Elements in Medicine and Biology (2025) Vol. 88, pp. 127616-127616
Closed Access

Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin‐induced cardiotoxicity
Jiajia Wei, Gongchun Lan, Wenfang Zhang, et al.
British Journal of Pharmacology (2025)
Closed Access

Ferroptosis and cuproptosis in periodontitis: recent biological insights and therapeutic advances
Tengyi Zheng, Fangguo Lu, Po‐Ying Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis
Bin Tu, Kai Song, Ze‐Yu Zhou, et al.
European Heart Journal (2025)
Closed Access

Hypoxia inducible factor-1α drives cancer resistance to cuproptosis
Zhou Yang, Wei Su, Xiyi Wei, et al.
Cancer Cell (2025)
Closed Access

Page 1 - Next Page

Scroll to top